Naloxone (also known as Narcan®) is a potentially life-saving medication approved by the Food and Drug Administration designed to rapidly reverse opioid overdose by reversing or blocking the effects of opioids. Ideally, any individual prescribed an opioid (equivalent to ≥50 morphine milligram equivalents per day) and are at risk of an opioid overdose, would also be prescribed naloxone.
The Ford Research Group developed a naloxone brochure for each of the types of naloxone administration (intranasal spray, intranasal, and intramuscular) so that they can serve as an educational resource for community pharmacists when dispensing naloxone to patients. The brochure was developed utilizing feedback from Community Advisors on Research Design and Strategies (CARDS) through the Wisconsin Network for Research Support (WINRS) at the University of Wisconsin-Madison.
The goal for these brochures is to: 1) educate patients and family members/caregivers on naloxone use and overdose, and 2) prepare family members/ caregivers on what to do in case of an overdose and how to administer naloxone, if needed.
The naloxone brochures are available to any community pharmacist to download and use as a patient resource when dispensing naloxone.
The naloxone brochures are available as a download for your pharmacy to use. To access the brochures please follow these instructions:
*The purpose of collecting your name and email address is for download tracking purposes only. If you have any questions, please feel free to contact us HERE.